David Garcia-Illescas

8PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 30, 2024
Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF.

Ester Bonfill-Teixidor, Almudena Neva-Alejo, Alexandra Arias

|Apr 03, 2023
Advances in immunotherapy for cervical cancer.

Juan Francisco Grau-Bejar, Carmen Garcia-Duran, David Garcia-Illescas

|Mar 06, 2023
Advances in immunotherapy in cervical cancer.

Juan-Francisco Grau, Lorena Farinas-Madrid, Carmen Garcia-Duran

|Jul 13, 2021
PARP inhibitors in advanced prostate cancer: when to use them?

Nely Díaz-Mejía, David García-Illescas, Rafael Morales-Barrera

|Mar 23, 2021
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.

Gino M Dettorre, Saoirse Dolly, Angela Loizidou

Pageof 2